FDA Inspection 1092477 — Kayla Y. Kamdar, MD

Kayla Y. Kamdar, MD — FEI 3015108871

The FDA completed an inspection of Kayla Y. Kamdar, MD on Feb 25, 2019 in Houston, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI)
End Date
Feb 25, 2019
Fiscal Year
2019
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Houston, TX (United States)

Additional Details

Clinical Investigator (CI)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.